DESIGN AND DEVELOPMENT OF SELF EMULSIFYING DRUG DELIVERY SYSTEM OF MARAVIROC
Journal Title: World Journal of Pharmaceutical Research - Year 2019, Vol 8, Issue 8
Abstract
Self emulsifying drug delivery systems (SEDDS) are isotropic mixtures of natural or synthetic oils, solids or liquid surfactants or alternatively, one or more hydrophilic solvents, and co-solvents or co-surfactants Maraviroc SEDDS formulation when diluted with 250 times gives globule size of 110 nm and zeta potential of -5.18. There is no significant difference in globule size when diluted with medias like 0.1 N HCl and Phosphate buffer of pH 6.8). Maraviroc drug release from the SEDDS formulation was performed in 0.1 N HCl and 87.92 (± 4.78) % released within 15 minutes. In-vitro drug diffusion study in dialysis membrane showed that 80.56 ± 2.81% maraviroc diffused from the SEDDS formulation in the Phosphate buffer of pH 7.4 in five hours, whereas only 42.86 (±2.12) % released from Maraviroc suspension at the same conditions. Maraviroc SEDDS formulation can be used in the treatment of AIDS.
Authors and Affiliations
Patel Rajendra
Keywords
Related Articles
- EP ID EP672871
- DOI -
- Views 189
- Downloads 0
RESISTANT BACTERIAL ISOLATES AMONG HIV-SEROPOSITIVE PREGNANT WOMEN IN AKURE METROPOLIS, ONDO STATE, NIGERIA
HIV serostatus of pregnant patients recruited was determined by HIV- 1/2 strip and confirmed by Abbott enzyme-linked immunosorbent assay. Quantification of CD4 and viral load for each patient was done using flow cytometr...
ANTIOXIDANT AND ANTIHYPERLIPIDAEMIC ACTIVITIES OF METHANOLIC EXTRACT OF CASSIPOUREA CONGOENSIS FRUIT IN TRITON X-100 INDUCED HYPERLIPIDAEMIC RATS
Cardiovascular diseases have become the leading and major clinical and public health problem. It is one of the major killer diseases in the world. The anti-hyperlipidaemic effect of methanol extract of Cassipourea congoe...
THE APPROVAL OF DRUG PROCESS: A REVIEW
It takes on average 12 years and over US$350 million to get a new drug from the laboratory onto the pharmacy shelf. Once a company develops a drug, it undergoes around three and a half years of laboratory testing, before...
BLOOD HYPEREOSINOPHILIA REVELING ADENOCARCINOMA WITH REARRAGEMENT ROS 1: A CASE REPORT
Lung cancer, like other solid tumors, is a rare cause of hypereosinophilia. We report a case of a young, non-smoking, 38-year-old woman presenting with a rare case of cancer "a pulmonary adenocarcinoma with ROS1 rearrang...
RECURRENCE IN CHRONIC SUBDURAL HEMATOMA (RETROSPECTIVE ANALYSIS)
138 patients had been admitted to neurosurgery teaching hospital, Baghdad, Iraq, diagnosed as a cases of chronic subdural hematoma treated surgically by burr hole irrigation, in the period from Jan.2015 to Dec. 2017. The...